A New Therapy for Alzheimer’s

Efforts to develop therapies that reverse the dementia of patients diagnosed with Alzheimer’s disease have produced few viable options. I believe one of the reasons for the inability to develop effective therapies is that inventors and researchers have focused on the wrong type of therapies, namely medicines and surgeries. Photobiomodulation therapy is a promising alternative.

The future of medicine rests with light and sound therapies of one form or another. This is why I am so excited to discover brand new, cutting edge therapies that use light to treat medical conditions like Alzheimer’s.

Photobiomodulation Therapy Research

A July 2018 University of California San Francisco study presented evidence on how photobiomodulation therapy reverses dementia. Eight adults diagnosed with dementia participated in the study. Four received 12 weeks of self-administered photobiomodulation treatments in their homes. Four were assigned to a control group. Treatments were administered using the Vielight Neuro Gamma device. Outcome measures were assessed at baseline, 6-weeks, and 12-weeks.

Findings revealed significant improvement in cognition and functional connectivity. Dr. Chao concluded that photobiomodulation therapy is a safe, non-pharmacological therapy that can be used to treat Alzheimer’s patients in their homes.

In another 2017 study, the effects of photobiomodulation  (PBM) that used red or near-infrared light was studied in five older adults with dementia.

After 12 weeks of treatment subjects showed significant improvements on the Cognitive Alzheimer’s Disease Assessment Scale. With only five subjects, the effect sizes had to be huge for significance to  be shown.

Caregivers who kept daily journals tracking experiences of the research subjects reported participants had:

1. Better sleep
2. Fewer angry outbursts
3. Decreased anxiety

Did Positive Results for Subjects Continue After Treatment was Suspended?

No. Precipitous declines were observed during the follow-up 4 week no-treatment period. Results suggest treatments need to continue for results to be sustained.

Saltmarche et al.(2017) Photomed Laser Surg. 2017 Aug;35(8)

Interview with Vielight Inventor Dr. Lew Lim

How Photobiomodulation Reverses Dementia

This video previews recent research at MIT that explains why light therapy offers a promising opportunity to reverse dementia associated with a diagnosis of Alzheimer’s disease.

1. Have you been unable to find effective therapies for dementia?
2. Are you desperate to find something that may help?

Watch this brief video that explains how the newly invented Neuro Gamma technology works

Consider taking a risk – and it will be a risk – and give photobiomodulation serious consideration. There are no reported side effects.

Vielight Neuro Gamma

The Neuro Gamma transcranial-intranasal near infrared (NIR) headset is engineered for increased efficacy. This device features improved transcranial clusters and updated microchip LED boosting technology that triples the power density of previous devices.  The device fits a wide variety of head shapes and sizes.

The Vielight engineering team has extracted an infusion of increased output using a pulsed near-infrared LED source which incorporates a microchip technology within the Neuro’s intra-nasal diode. The 40 Hz pulse rate correlates with EEG gamma brain wave entrainment  to facilitate a much stronger effect on memory and cognition enhancement.

As covered in the audio clip with this post I recommend you investigate the Vielight Neuro Duo engineered by Vielight which is the world’s only transcranial-intranasal brain photobiomodulation (PBM) device and  the result of years of engineering and research. Clinical research with our technology has produced improvements in cognition, memory and blood flow.

Photobiomodulation Device Warranty

The Vielight company is confident in its new invention and wants as many people to use it as possible right now.

When you purchase the Vielight Neuro Gamma, you will have six months to see if helps reverse your dementia. If for any reason you are not satisfied with your progress, you can return the device to Vielight for an 80% refund.

I have never heard of a company that is so confident in their product. The warranty is the most generous I have ever encountered. As a result, the risk involved is reduced significantly. The company obviously have high confidence in their new photobiomodulation invention as do I.

Cost of Neuro Gamma Device

Vielight has generously offered a 10% discount for any purchases through their website.  The retail cost of the Neuro Duo device is relatively expensive – about $1800 – you can claim a 10% discount with the discount code  healing4me.

Use the device for six months to explore if it offers symptomatic relief. Most people are happy with the results (9 out of 10 users) but not everyone as is the case with any therapeutic option.

If it does not offer a celebration of symptom relief you anticipated, return the device within the 6 month period after purchase for an 80% refund of the purchase price.

Everyone in the family can use the therapy.

The Vielight organization obviously  has confidence in their product which is a very encouraging sign. I have never heard of any company that offered a 6 month warranty.

How to Claim the 10% Vielight Discount

First, visit the Vielight website: www.vielight.com

Second, find the listing of the Gamma Neuro  device. Be sure to enter the coupon code healing4me on the coupon field of the shopping cart to claim your 10% discount which will automatically be applied. Please also email me your experience with using it after a month (or longer) of use.

Or, call the company to order over the phone. They are most happy to answer any and all questions: 1-855-875-6841 (North America) | 1-647-201-5499 (International) – [ 8.30 am – 4.30 pm EST ]|. Given them the coupon code to claim the 10% discount.

Photobiomodulation Mechanism

Visible red and near infrared light energy stimulates cells to generate more energy facilitating self-repair. The healing takes place within the mitochondria through an enzyme called cytochrome c oxidase. This enzyme accepts and converts the light (or photonic) energy into cellular energy (ATP) and other gene transcription factors leading to cellular repair and regeneration.

Will Photobiomodulation Therapy Interfere with My Daily Life?

No. You are welcome to receive the therapy while working, reading or doing anything really.  Dr. Lim, the inventor, recommends that people with more serious health issues such as Alzheimers might be advised to do the therapy at night while going to sleep. The treatment duration lasts only 20 minutes.

Interview with the Inventor, Dr. Lew Lim

Dr. Lew Lim is an engineer and a Doctor of Natural Medicine with additional diplomas in Medical Neuroscience and Business. He obtained his degrees and diplomas from the University of California at Berkeley, University of Sheffield, Duke University, Quantum University and The Chartered Institute of Management Accountants, UK.

Photobiomodulation Reverses Dementia Summary

This post presents an explanation for how photobiomodulation reverses dementia and is a promising therapy for Alzheimers.

Robert Rodgers PhD
Zero Point Healers
robert@zeropointhealers.com
Olympia Washington
877-526-4646

The abstract of a study below reports that photobiomodulation light therapy increases the speed of information processing and enhances brain function. Researchers are now celebrating more and more confirmatory evidence that photobiomodulation offers the opportunity to reverse dementia and is a viable therapy for persons diagnosed with Alzheimer’s.

The gold standard photobiomodulation devices have been developed by Vielight: https://www.vielight.com
Claim a 10% discount on all devices with the coupon code healing4me

Photobiomodulation Light Therapy Study

Biomed Opt Express. 2020 Sep 22;11(10):5783-5799. Transcranial photobiomodulation-induced changes in human brain functional connectivity. Elizabeth L Urquhart , Hashini Wanniarachchi , Xinlong Wang , Francisco Gonzalez-Lima , George Alexandrakis, Hanli Liu 

Abstract

Watch the video below which covers issues with smart electrical meters and their affect on chronic illnesses like Alzheimers.

Watch now: Take Back Your Power 2017 is now forever free to stream

Research on Smart Electrical Meters and Alzheimers

Curr Alzheimer Res

Curr Alzheimer Res. 2022;19(2):119-132. Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence. Martin L Pall 

Abstract

Electronically generated electromagnetic fields (EMFs), including those used in wireless communication such as cell phones, Wi-Fi and smart meters, are coherent, producing very high electric and magnetic forces, which act on the voltage sensor of voltage-gated calcium channels to produce increases in intracellular calcium [Ca2+]i. The calcium hypothesis of Alzheimer’s disease (AD) has shown that each of the important AD-specific and nonspecific causal elements is produced by excessive [Ca2+]i. [Ca2+]i acts in AD via excessive calcium signaling and the peroxynitrite/oxidative stress/inflammation pathway, which are each elevated by EMFs.An apparent vicious cycle in AD involves amyloid-beta protein (Aβ) and [Ca2+]i. Three types of epidemiology suggest EMF causation of AD, including early onset AD. Extensive animal model studies show that low intensity EMFs cause neurodegeneration, including AD, with AD animals having elevated levels of Aβ, amyloid precursor protein and BACE1. Rats exposed to pulsed EMFs every day are reported to develop universal or near universal very early onset neurodegeneration, including AD; these findings are superficially similar to humans with digital dementia. EMFs producing modest increases in [Ca2+]i can also produce protective, therapeutic effects. The therapeutic pathway and peroxynitrite pathway inhibit each other.

A summary of 18 different findings is provided, which collectively provide powerful evidence for EMF causation of AD. The author is concerned that smarter, more highly pulsed “smart” wireless communication may cause widespread very, very early onset AD in human populations.

Robert Rodgers PhD
Alzheimersrecovery.com

Current application and future directions of photobiomodulation in central nervous disease

Neural Regen Res (Neural Regeneration Research) 2021 Jun;16(6):1177-1185.